Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes.

Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes.

Show other versions (1)

Bibliographic Details
Main Authors:	Coleman, R, Stevens, R, Retnakaran, R, Holman, R
Format:	Journal article
Language:	English
Published:	2007

Similar Items

Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in Type 2 diabetes
by: Coleman, R, et al.
Published: (2007)

Framingham risk equations underestimate coronary heart disease risk in diabetes.
by: Stevens, R, et al.
Published: (2005)

Evaluating SCORE and Framingham fatal coronary heart disease risk equations using UKPDS data
by: Coleman, R, et al.
Published: (2004)

Framingham equations underestimate cardiovascular risk compared with the UKPDS risk engine in people with Type 2 diabetes
by: Price, H, et al.
Published: (2007)

Performance of the UKPDS Risk Engine and the Framingham risk equations in estimating cardiovascular disease in the EPIC-Norfolk cohort
by: Simmons, R, et al.
Published: (2008)

Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort.
by: Simmons, R, et al.
Published: (2009)

Framingham score in the evaluation of cardiovascular risk in diabetics
by: Mariana Costa Larré, et al.
Published: (2015-02-01)

Estimating cardiovascular disease risk for individuals with Type 2 diabetes: the new UKPDS Risk Engine
by: Coleman, R, et al.
Published: (2007)

Estimating risk of clinically evident neuropathy in Type 2 diabetes: a UKPDS risk equation
by: Coleman, R, et al.
Published: (2006)

Estimation of Cardiovascular Risk by Framingham Score in a Cross-sectional Sample of Schizophrenia Inpatients
by: Cosmin-Ioan MOGA, et al.
Published: (2023-01-01)

Assessing Framingham cardiovascular risk scores in subjects with diabetes and their correlation with diabetic retinopathy
by: S Vivekanandan
Published: (2012-01-01)

Association of Arterial Stiffness Indices with Framingham Cardiovascular Disease Risk Score
by: Lin Jin, et al.
Published: (2022-08-01)

Cardiovascular risk assessment by Framingham score pre and post kidney transplant
by: Marcos Vinicius de Sousa, et al.
Published: (2016-03-01)

Where to Sit? Type of Sitting Matters for the Framingham Cardiovascular Risk Score
by: Katja Borodulin, et al.
Published: (2016-08-01)

Assessing Framingham cardiovascular risk scores in subjects with diabetes and their correlation with diabetic retinopathy-Comment
by: Sachidanandam Vivekanandan
Published: (2013-01-01)

Assessing Framingham cardiovascular risk scores in subjects with diabetes and their correlation with diabetic retinopathy: Comment
by: Cynthia Arunachalam
Published: (2012-01-01)

Framingham risk scores and anthropometric measurements in predicting cardiovascular risks among Malay men
by: Moy, Foong Ming, et al.
Published: (2008)

The Association of Thyroid Volume with Framingham Risk Score and Cardiovascular Risk Factors in Postmenopausal Women
by: Hünkar Ağgül, et al.
Published: (2023-09-01)

Incident nephropathy in type 2 diabetes: a UKPDS Risk Equation
by: Coleman, R, et al.
Published: (2005)

A cardiovascular risk calculator for type 2 diabetes
by: Coleman, R, et al.
Published: (2005)

Comparative study of prognostic value for coronary disease risk between the U.K. Prospective diabetes study and framingham models: response to Protopsaltis et al.
by: Stevens, R, et al.
Published: (2004)

Identification of the Framingham Risk Score by an Entropy-Based Rule Model for Cardiovascular Disease
by: You-Shyang Chen, et al.
Published: (2020-12-01)

Cardiovascular risk in primary care: comparison between Framingham Score and waist circumference
by: Nina Vitória de Souza Silva Andrade, et al.
Published: (2021-12-01)

Machine learning provides evidence that stroke risk is not linear: The non-linear Framingham stroke risk score
by: Orfanoudaki, Agni, et al.
Published: (2021)

Machine learning provides evidence that stroke risk is not linear: The non-linear Framingham stroke risk score.
by: Agni Orfanoudaki, et al.
Published: (2020-01-01)

Comparative performance of pooled cohort equations and Framingham risk scores in cardiovascular disease risk classification in a slum setting in Nairobi Kenya
by: Frederick M. Wekesah, et al.
Published: (2020-06-01)

Reference distributions of aortic calcification and association with Framingham risk score
by: Steven R. Horbal, et al.
Published: (2023-06-01)

Prediction of cardiovascular disease risk using framingham risk score among office workers, Iran, 2017
by: Mahmood Reza Nakhaie, et al.
Published: (2018-01-01)

Framingham cardiovascular disease risk scores and incident frailty: the English longitudinal study of ageing.
by: Gale, C, et al.
Published: (2014)

Framingham cardiovascular risk in patients with obesity and periodontitis
by: Juliana Rico Pires, et al.
Published: (2014-01-01)

Cardiovascular Events in People with Type 2 Diabetes: Performance of Framingham, UKPDS, and ADVANCE Risk Equations
by: Elaheh Yaghoubvand, et al.
Published: (2021-11-01)

Re-estimation improved the performance of two Framingham cardiovascular risk equations and the Pooled Cohort equations: A nationwide registry analysis
by: Christine Wallisch, et al.
Published: (2020-05-01)

Risk Assessment for Cardiovascular Disease Using the Framingham Risk Score and Globorisk Score Among Newly Diagnosed Metabolic Syndrome Patients
by: Adil SO, et al.
Published: (2023-09-01)

Framingham risk prediction equations for incidence of cardiovascular disease using detailed measures for smoking
by: John McNeil, et al.
Published: (2010-09-01)

The Evaluation of Cardiovascular Risk Factors Knowledge Level, Framingham Risk Scores and Related Factors in Patients with Rheumatoid Arthritis
by: Köksal Sarıhan, et al.
Published: (2021-07-01)

Coronary age as a risk factor in the modified Framingham risk score
by: Whitcomb Brian W, et al.
Published: (2004-04-01)

Sleep duration and Framingham´s cardiovascular risk score: results from the Hoveyzeh Cohort Study (HCS)
by: Bahman Cheraghian, et al.
Published: (2023-11-01)

KORELASI ANTARA PROTEINURIA DAN FRAMINGHAM RISK SCORE DALAM PENILAIAN RISIKO CARDIOVASCULAR DISEASE
by: Kevin Prasetya Raharjo, et al.
Published: (2017-05-01)

Comparison of original and modified Q risk 2 risk score with Framingham risk score - An Indian perspective
by: Puneet Aggarwal, et al.
Published: (2021-05-01)

Impact of modifiable risk factors on prediction of 10-year cardiovascular disease utilizing framingham risk score in Southwest Iran
by: Nader Saki, et al.
Published: (2023-07-01)